These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 15025845

  • 1. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B.
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [Abstract] [Full Text] [Related]

  • 2. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH, Lyoussi B, Hernández-Hernández R, Velasco M.
    Am J Ther; 2007 Mar; 14(4):386-402. PubMed ID: 17667215
    [Abstract] [Full Text] [Related]

  • 3. MARRIAGE: A Randomized Trial of Moxonidine Versus Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters.
    Valensi P, Jambart S.
    J Cardiovasc Pharmacol Ther; 2024 Mar; 29():10742484241258381. PubMed ID: 38828542
    [Abstract] [Full Text] [Related]

  • 4. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I, Almazov VA, Shlyakhto E.
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [Abstract] [Full Text] [Related]

  • 5. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN, Graham BR, Owens CW.
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 9. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN, Owens CW, Graham BR.
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN, Graham BR.
    J Cardiovasc Pharmacol; 1996 Aug; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [Abstract] [Full Text] [Related]

  • 13. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA.
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antihypertensive therapy in patients with metabolic syndrome.
    Segura J, Ruilope LM.
    Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):493-7. PubMed ID: 16914961
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of ramipril on sympathetic nervous system function in older patients with hypertension.
    Lee CC, Sidani MA, Hogikyan RV, Supiano MA.
    Clin Pharmacol Ther; 1999 Apr; 65(4):420-7. PubMed ID: 10223780
    [Abstract] [Full Text] [Related]

  • 19. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF, Mann JF.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract] [Full Text] [Related]

  • 20. RAS inhibition in hypertension.
    Ibrahim MM.
    J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.